Abstract:Objective To understand the characteristics of mutations in BCR-ABL1 kinase domain mutation,these chronic myeloid leukemia (CML) and Ph positive acute lymphoblastic leukemia (ALL)patients who got imatinib treatment had poor effect.Methods Totally 177 CML patients and 33 Ph( + )ALL patients were selected at Beijing Dao-Pei Hospital from Sep.2007 to Dec.2010.All of them were Chinese patients.Totally 243 bone marrow or peripheral blood specimens were collected from the patients,who had early effect,then resistance emergenced,or for more than 3 months of poor efficacy.Extracted total RNA from the specimens' nuclear cells,reversed transcription to cDNA.Amplified the whole span of BCRABL1 fusion kinase gene by nest PCR (from 242 to 493 amino acid coding sequence),used the type AB3130XL gene sequencing instrument determinate the gene sequence of ABL1 kinase region and then used the Variant Reporter V1.0 software to analyze the results of gene mutations.Results Thirty-two kinds of different mutations were detected of ABL1 gene mutations,accounting for 34.2％ (83/243 cases).Among them,the T315I was 12％ (10/83),mutation rate was the highest,followed by Y253H was 11％ (9/83),G250E was 7％ (6/83),E255K was 7％ (6/83),M351T was 6％ (5/83),E459K was 5％ (4/83) ;Q252H,D276G,F317L,E355G,F359V,H396R were all 4％ (3/83).Three cases of insertion mutations were found,including 2 cases of 357-358insk,1 case of V304RfsX17.Seven patients had found existence two or more point mutations.The multiple drug resistance mutations might exist in the same leukemia clone.The same individual was not only contain common resistance mutations,but also rare point mutations,insertion mutations.The mutations might be lead to loss of kinase activity.Conclusions Under the imatinib drugs pressure,the ABL1 gene mutation in leukemia cells appears randomly,and results in different resistant clones.Different resistant clones can coexist in the same patients in vivo; resistant clones not only contain point mutations,but also contain inserted deletion mutations.

Types of BCR-ABL Fusion Gene in Chronic Myeloid Leukemia and Its Clinical Significance

[Cytogenetic and Molecular Analysis of 1193 Cases with Chronic Myeloid Leukemia].

Study on relationship between different bcr/abl fusion transcripts and clinical manifestations in chronic myeloid leukemia]

Clinical significance of BCR-ABL fusion gene subtypes in chronic myelogenous and acute lymphoblastic leukemias.

Detection of FLT3/ITD, JAK2(V617F) and NPM1 gene mutations in chronic myelomonocytic leukemia

Clinical Significance of Detection of bcr/abl Fusion Gene in theDiagnosis and Minimal Residual Disease of Chronic Myeloid Leukemia

[Effect of Co-Expressing M-bcr/abl and M-Bcr/abl Fusion Gene Transcripts on the Clinical Features of Patients with Chronic Myelogenous Leukemia at Diagnosis].

Clinical characteristics and prognostic significance of chronic myeloid leukemia with rare BCR-ABL1 transcripts.

Prevalence and Outcomes of Uncommon BCR‐ABL1 Fusion Transcripts in Patients with Chronic Myeloid Leukaemia: Data from a Single Centre

The impact of the BCR-ABL oncogene in the pathology and treatment of chronic myeloid leukemia

Application of real-time quantification polymerase chain reaction in detecting the expression of BCR-ABL in chronic myelogenous leukemia cells

Characteristics of the TCR Vβ Repertoire in Imatinib-Resistant Chronic Myeloid Leukemia Patients with ABL Mutations

Heterogeneous BCR-ABL1 signal patterns identified by fluorescence in situ hybridization are associated with leukemic clonal evolution and poorer prognosis in BCR-ABL1 positive leukemia

Expression of the CDH13 gene and BCR/ABL fusion gene in chronic myeloid leukemia patients and their relationship

Molecular Detection of BCR-ABL in Chronic Myeloid Leukemia.

Distribution of BCR::ABL1 Transcripts in the Different Clinical Phases of Chronic Myeloid Leukemia: Effect on Hematological Parameters and Patient Survival

Impact of BCR-ABL1 Transcript Type on Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated with Imatinib

The characteristics of ABL1 gene mutations in 210 cases of Chinese patients who have imatinibresistant in chronic myeloid leukemia and Ph positive acute lymphoblastic leukemia

[Clinical and Laboratory Characteristics of 12 Ph/BCR-ABL Positive Acute Myeloid Leukemia Patients].

Chronic myeloid leukemia with two rare fusion gene transcripts of atypical BCR::ABL: A case report and literature review

Study on the cases with BCR/ABL fusion gene positively detected by fluorescence in situ hybridization